— Know what they know.
Not Investment Advice

EMD.AX ASX

Emyria Limited
1W: -10.0% 1M: +0.0% 3M: +9.8% YTD: -18.2% 1Y: +0.0% 3Y: -41.8% 5Y: -78.8%
A$0.04 ($0.03)
+0.00 (+0.00%)
 
Weekly Expected Move ±10.2%
A$0 A$0 A$0 A$0 A$0
ASX · Healthcare · Medical - Healthcare Information Services · Tech Score Sell · Power 43 · A$25.8M mcap · 425M float · 0.338% daily turnover
#11 of 20
Medical - Healthcare Information Services
Healthcare · Micro Cap · 12 peers
Market Share
0.1%
Top 4 Concentration: 98.2%

Peer Comparison

Symbol Mkt Cap P/E ROE % ROIC % Net Mgn % Rev Grw % Piotroski Signal 1Y Ret %
EMD.AX Emyria Limited $30M -5.7 -164.3 -300.5 -153.2 39.0 4 BEARISH 0.0
CGS.AX Cogstate Limited $580M 33.5 49.6 94.6 22.4 0.8 6 BULLISH 83.8
RHT.AX Resonance Health Limited $30M 22.5 -2.0 13.9 0.6 106.4 4 BULLISH 97.2
AYA.AX Artrya Limited $560M -19.5 -87.5 -794.4 -103142.9 — 5 LEAN BULL 78.7
ALC.AX Alcidion Group Limited $140M 60.0 4.4 15.2 3.6 19.3 7 LEAN BULL 6.4
VHL.AX Vitasora Health Limited $30M — — — — — — LEAN BEAR —
TRI.AX TrivarX Limited $10M — — — — — — LEAN BEAR —
PME.AX Pro Medicus Limited $17B 61.9 119.2 122.9 68.7 65.7 6 BEARISH -47.2
SHG.AX Singular Health Group Ltd $60M -8.9 -212.3 -1749.3 -355.2 28.1 4 BEARISH -42.2
M7T.AX Mach7 Technologies Limited $50M -5.9 -35.0 -67.5 -22.3 4.3 4 BEARISH -28.1
BMT.AX Beamtree Holdings Limited $30M -1.6 -69.3 -35.6 -105.1 14.7 3 BEARISH -57.5
PCK.AX PainChek Limited $20M -2.2 20194.8 416.4 -210.8 35.3 2 BEARISH -77.0
PKY.AX Pathkey.AI Ltd $30M -2.9 -7.5 -6.5 -7995.4 — 2 BEARISH —

Profile Radar

Valuation vs Profitability

Performance Comparison

Industry Market Share

EMD.AX vs Benchmarks

ROIC
EMD.AX
-300.5
Industry
0.3
Gross Margin
EMD.AX
-95.5
Industry
53.8
Op Margin
EMD.AX
-154.3
Industry
-15.3
Net Margin
EMD.AX
-153.2
Industry
-21.2
Sector
-157.4
Revenue Growth
EMD.AX
39.0
Sector
0.8
P/E Ratio
EMD.AX
-5.7
Sector
17.0
ROE
EMD.AX
-164.3
Sector
-70.3
Piotroski F
EMD.AX
4.0
Sector
3.0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms